Skip to main content

Nino's News

Welcome to Nino’s News. Our guest blogger, Anthony “Nino” Sireci, M.D. is vice president, clinical biomarker and diagnostics development, Loxo Oncology at Lilly. Dr. Sireci is a board-certified Clinical Pathologist and a practicing molecular pathologist. Prior to joining Loxo, he was an Assistant Professor of Pathology and Cell Biology at Columbia University and a medical director in the Laboratory of Personalized Genomic Medicine at Columbia Medical Center.

Filter

oncogene testing RET lung cancer

Looking Ahead: The Future of Diagnostic Testing for Patients

By: Anthony Sireci, M.D., senior vice president, clinical biomarkers and diagnostics development, Loxo@Lilly Over the…
January 7, 2024
biomarker testing RET cancer

Finding the Right Time to Ask About Biomarker Testing

By: Anthony Sireci, M.D., senior vice president, clinical biomarkers and diagnostics development, Loxo@Lilly Increasingly, cancer…
July 27, 2023
cancer medical care team

Understanding the Role of a Care Team in Treatment Planning

By: Anthony Sireci, M.D., senior vice president, clinical biomarkers and diagnostics development, Loxo@Lilly When someone…
April 18, 2023
lung cancer research

The Importance of Biomarker Testing When Facing RET-Altered Cancers

Over the last decade and a half, there has been a rapid expansion of precision…
September 12, 2022